Fig. 4.
From: Pediatric low-grade glioma in the era of molecular diagnostics
Molecular testing decision tree for pediatric low-grade glioma. *The frequency with which tumors harbor an FGFR1Â mutation and additional mutations justifies continued testing regardless of status. AG: angiocentric glioma, DNET: dysembryoplastic neuroepithelial tumour, GNT: glioneuronal tumor, ODG: oligodendroglioma, PA: pilocytic astrocytoma, GG: ganglioglioma, PXA: pleomorphic xanthoastrocytoma, DA: diffuse astrocytoma